综合性瘤治疗模式:NCCN成员机构的实践模式
Angela F Bazzell1, Lydia T Madsen1, Lindsey Bandini2
1From Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
Journal of the advanced practitioner in oncology
|February 16, 2026
概括
癌症患者寻求综合性瘤学 (IO),但面临着难以获得的挑战. 对国家综合癌症网络 (NCCN) 中心的调查显示,IO服务提供广泛,但在交付和资金方面存在显著差异.
科学领域:
- 综合性瘤学是一种综合性瘤学.
- 提供癌症护理服务.
- 医疗服务研究 医疗服务研究
背景情况:
- 患有癌症的患者通常希望使用综合性瘤学 (IO) 实践.
- 患者很难找到安全有效的IO服务和提供者.
- 国家综合癌症网络 (NCCN) 调查了其成员机构的IO实践.
研究的目的:
- 调查国家综合癌症网络 (NCCN) 成员机构的整合性瘤学 (IO) 实践.
- 了解癌症中心如何向患者提供IO服务.
- 识别IO服务提供中的变化和潜在的最佳实践.
主要方法:
- 一个基于网络的调查被分发给了NCCN成员机构的代表.
- 描述性统计数据被用来编制调查结果.
- 该调查重点关注提供的IO服务类型和患者获取方法.
主要成果:
- 所有29个被调查的NCCN中心都提供IO服务,包括营养,压力管理,心身实践,物理治疗,针和按摩.
- 患者的访问主要是通过提供者转介,有一些自我调度选项.
- 在IO服务融资模式 (自付,保险,慈善) 和推算法中存在显著差异.
结论:
- 在NCCN成员机构如何提供综合性瘤学 (IO) 服务方面存在相当大的差异.
- 调查结果为开发IO服务的医疗机构提供了指导,并突出了协调最佳实践的领域.
- 虽然对于非学术环境来说具有挑战性,但这些数据为癌症提供者提供了有关患者通常寻求的IO服务的信息.
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...